Sec. 210. Orphan drug clarification

81 words·~1 min read·/bill/116/s/1895/rs/section-210

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Section 527(c) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360cc(c) ) is amended by adding at the end the following: This subsection applies to any drug designated under section 526 that was approved under section 505 of this Act or licensed under section 351 of the Public Health Service Act after the date of enactment of the FDA Reauthorization Act of 2017, regardless of the date of on which such drug was designated under section 526. .

Connectionstraces to 1

Traces to 1 document

U.S. Code

Protection for drugs for rare diseases or conditions
§ 360cc

Citation graph

cites case law

Sec. 210

Orphan drug clarification

U.S.C.§ 360cc

Cites 1Cited by 0 across 0 sources